BRYNJELSEN SEAN 4
4 · Eton Pharmaceuticals, Inc. · Filed Dec 12, 2025
Insider Transaction Report
Form 4
BRYNJELSEN SEAN
DirectorPresident & CEO10% Owner
Transactions
- Tax Payment
Common Stock
2025-12-12$16.83/sh−6,732$113,300→ 2,894,281 total
Footnotes (3)
- [F1]Shares withheld by the Issuer to satisfy applicable withholding taxes upon the vesting of restricted stock units.
- [F2]The shares were sold in multiple trades at prices ranging from $16.66 to $16.98. The price reported above reflects the weighted average sales price.
- [F3]The Reporting Person will provide upon request by the Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price.